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ABSTRACT 
A simple, precise, rapid and accurate reverse phase HPLC method was developed for the estimation of Gabapentin and Amitriptyl ine 
hydrochloride in bulk and tablet dosage form. A C8 Column (250mm x 4.6 mm, 5µm. particle size)   was used in this method. The  mobile phase 
comprises of Acetonitrile: 0.1% Orthophosphoric acid (60:40v/v) with flow rate 1ml/min (UV detection at 210 nm).  The retention time for 
Gabapentin was 1.86min and Amitriptyline was 2.18min.The detection concentration was linear over 300-1500 μg/mL for Gabapentin and 2.5-
12.5 μg/mL for amitriptyline hydrochloride. Regression equation of Gabapentin and Amitriptyline hydrochloride were found to be y = 73.22x - 
7921 and y = 8748.x + 16611 respectively with regression co-efficient of Gabapentin and Amitriptyline is 0.995 and 0.999.  So the present work 
is aimed for Development of simple and reproducible chromatographic (RP-HPLC) method for simultaneous estimation of Gabapentin and 
Amitriptyline hydrochloride. The developed method was successfully validated in accordance to ICH guidelines. Hence, this method can be 
conveniently adopted for the routine analysis in quality control laboratories. 
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1. INTRODUCTION 
 It is an antiepileptic medication. It  decreases  pain  and 
seizures  by  modulating  calcium  channel  activity  of  the  
nerve  cells and amitriptyline  is  used  in  the  treatment  of  
depression  and  neuropathic  pain. The  IUPAC  name  of  the  
gabapentin is 2-[1-(aminomethyl)  cyclohexyl] (fig.1)[1] acetic 
acid with molecular formula : C9H17NO2  and  molecular  
weight  207.70. Gabapentin is freely soluble in water, 
alkaline and acidic solution, sparingly soluble in methanol [1] 
Gabapentin is well absorbed orally and excreted unchanged 
in urine with t1/2 of 6 hrs[2]  Gabapentine and pregabaline 
have very little liability for causing metabolic besed drug 
drug interaction, particularly when used in combination with 
other antiepileptic drugs (AEDs) because they are not 
metabolized in humans, and 90% drurs are excreted through 
kidney[3, 8] 
 
Fig.1. Gabapentin 
Molecular Formula: C9H17NO2 
Molecular Weight: 207.70 g/mol 
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For the treatment of depression and neuropathic pain 
Amitriptyline HCL is used. Amitriptyline HCL increases the 
levels of chemical messengers in the brain that help in 
regulating the disposition and treat depression. IUPAC name 
of amitriptyline is 3-(5, 6- dihydrodibenzo [2,-b: 2', 1'-f] 7-
annulen-11-ylidene)- N, dimethyl propan (fig.2) with 
molecular formula: C20H23N, HCL and molecular weight is 
313.87. It is freely soluble in water and alcohol [1].  It is a 
colourless crystals or a white or almost white powder, 
odourless. It have less anticholinergic, less sedative and 
more stimulant action than amitriptyline[4]. It is tricyclic 
antidepressants which can elevate mood in depressive 
illness [5, 6].Amitriptyline increases the levels of chemical 
messengers in the brain that help in regulating the mood and 
treat depression [7, 8].                                 
 
 
Fig.2. Amitriptyline Hydrochloride 
Molecular Formula: C20H24ClN 
Molecular Weight: 313.864 g/mol 
2. EXPERIMENTAL: 
Instrumentation: 
Chromatography was performed with Systronic HPLC 
system provided with Hamilton Syringe, auto sampler and 
UV detector.  
Reagents and Materials: 
Gabapentin and Amitriptyline Hydrochloride were obtained 
as gift sample from Sun pharma laboratories Ltd, 
Pharmaceutical Company in Goa Industrial Estate, Goa, India. 
HPLC grade Acetonitrile, Water and O-Phosphoric acid 
procured from Research lab fine chem Industries Mumbai. 
Preparation of mobile phase: 
1000 ml of mobile phase was prepared by mixing 600 ml 
acetonitrile and 400 ml 0.1 % Orthophosphoric acid. 
Degassing of mobile phase: 
The prepared mobile phase was degassed by ultrasonication 
for 15 min, so to avoid the disturbances caused by dissolved 
gases. 
Filtration of mobile phase: 
The degassed mobile phase was filtered through 0.45 μm 
filters to avoid the column clogging due to smaller particles.  
Preparation of standard stock solution: 
Standard stock solution of Gabapentin and Amitriptyline 
Hydrochloride were prepared separately by dissolving 10 
mg of drug in 10 ml of mobile phase to get concentration of 
1000 µg/ml. From the respective standard stock solution, 
working standard solution was prepared containing 
300µg/ml of GABA and 10µg/ml of AMTR separately in 
mobile phase. 
Selection of Detection Wavelength: 
From the standard stock solution further dilutions were 
made using methanol and scanned over the range of 200 - 
400 nm and the spectra was obtained. It was observed that 
both the drug showed considerable absorbance at 210nm.  
Loading of standard solution:  
Standard solution of Gabapentin and Amitriptyline 
Hydrochloride were loaded in to the HPLC  
Vial stand placed in sample tray & were injected.
 
 
Fig. 3: Chromatogram of standard mixture of Gabapentin and Amitriptyline Hydrochloride. 
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Preparation of sample solution (Tablet Formulation 
Analysis): 
Ten tablets each containing 300 mg of GABA and 10 mg of 
AMTR and was weighed and powdered (Each uncoated 
tablet contains Gabapentin IP 300 mg and Amitriptyline 
Hydrochloride IP 10 mg). Powder equivalent to 300 mg of 
Gabapentin (10 mg of AMTR) was transferred to 10 ml 
volumetric flask and was diluted with mobile phase then 
ultrasonication was done and volume made to 10 ml (3000 
µg/ml of GABA and 1000 µg/ml of AMTR) with mobile phase 
then further dilutions were made with mobile phase to get 
the final concentration of 300 µg/ml of GABA and 10 µg/ml 
of AMTR. Solution was filtered by 0.45 μm nylon membrane 
filters by using vacuum filter. Tablet formulation analysis 
was carried out as mentioned under section Tablet 
Formulation Analysis. Procedure was repeated for six times. 
Sample solution was injected and area was recorded for each 
drug. Concentration and % purity was determined from 
linear equation shown in (Table 1) 
  
Table 1: Assay results for GABA and AMTR      
 
Sr. no. 
GABA AMTR 
Peak area 
Amount 
recovered 
(µg/ml) 
% 
recovery 
Peak area 
Amount 
recovered 
(µg/ml)) 
% 
recovery 
1 14113.9 300.941 100.314 103260.4 9.905053 99.051 
2 14015 299.590 99.863 103014.7 9.876966 98.770 
3 13956.2 298.787 99.596 105017.8 10.10594 101.059 
4 13794.8 296.583 98.861 103960.4 9.985071 99.851 
5 14313.6 303.668 101.223 104196.7 10.01208 100.121 
6 13993.2 299.293 99.764 104087.3 9.999577 99.996 
Mean 14031.117 299.810 99.937 103890.0 9.981 99.808 
% RSD 1.233 0.789 0.788 0.689 0.820 0.820 
 
3. METHOD VALIDATION: [9, 10, 11, 12, 13] 
Linearity: 
The linearity for GABA and AMTR were assessed by analysis 
of combined standard solution in the range of 300-
1500μg/ml and 2.5-12.5μg/ml respectively. Correlation 
coefficient for calibration curve GABA and AMTR was found 
to be 0.995 and 0.999. The results obtained are shown in 
(Table 2 and Fig.3) for GABA and in (Table 3 and Fig.4) for 
AMTR. Regression equation of GABA and AMTR were found 
to be y = 73.22x - 7921(Figure 3) and y = 8748.x + 16611 
(Figure 4).  
 
Table 2: Linearity study of GABA 
Replicates 
Concentrations of GABA (µg/ml) 
300 600 900 1200 1500 
Peak Area 
1 16131.9 33181.3 56733.9 82633.2 101217.8 
2 16123.5 33191.4 56758.3 82642.3 101214.9 
3 16124.9 33167.8 56747.9 82660.5 101208.3 
4 16049.6 33185.9 56731.4 82687.1 101226.5 
5 16123.7 33169.4 56768.8 82649.2 101219.9 
6 16129.9 33192.8 56721.9 82649.1 101219.4 
Mean 16113.92 33181.43 56743.70 82653.57 101217.80 
Std.dev. 31.70 10.76 17.80 18.73 6.02 
%RSD 0.20 0.03 0.03 0.02 0.01 
      
 
 
Fig. 3: Calibration curve for AMTR 
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Table 3: Linearity study of AMTR 
Replicates 
Concentrations of AMTR (µg/ml) 
2.5 5 7.5 10 12.5 
Peak Area 
1 38168 61397.1 81479.2 103981.9 126199.4 
2 38159.8 61348.8 81429.4 103977.1 126184.8 
3 38128.9 61358.3 81489.1 103933.9 126198.4 
4 38159.2 61349.9 81465.0 103961.1 126178.2 
5 38109.3 61356.8 81482.1 103959.5 126198.5 
6 38141.6 61318.9 81462.1 103948.5 126189.0 
Mean 38144.47 61354.97 81467.82 103960.33 126196.70 
Std.dev. 22.33 25.12 21.46 17.81 8.80 
%RSD 0.06 0.04 0.03 0.02 0.01 
 
                                                     
 
Fig. 4: Calibration curve for AMTR 
Precision: 
Intra-day: 
The intraday precision for Gabapentin and Amitriptyline Hydrochloride is shown in table (4 & 5). The % RSD for intraday 
precision was found to be 0.773 for Gabapentin and 0.500 for Amitriptyline Hydrochloride 
                                   
Table 4: Intra-day precision study GABA 
Concentration 
(µg/ml) 
Area 
% 
Recovery 
Mean % 
Recovery 
± SD 
Mean % 
Recovery 
±  % RSD 
300 
14001.2 99.801 
100.010± 
0.302 
99.508 
±0.773 
14123.3 100.356 
14017.1 99.873 
600 
35134.2 98.004 
98.898± 
1.019 
35432.2 98.683 
36014.1 100.007 
900 
57423.8 99.161 
99.617± 
0.531 
58108.3 100.199 
57642 99.492 
 
y = 8748.4x + 16611 
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Table 5: Intra-day precision study AMTR 
Concentration 
(µg/ml) 
Area 
 
% 
Recovery 
Mean % 
Recovery ± SD 
Mean%                   
Recovery± % RSD 
2.5 
38424.6 99.742 
99.118 
±0.582 
99.169 
±0.500 
38172.6 98.590 
38267.4 99.023 
 
5 
60124.8 99.483 
99.503 
±0.045 
60156.2 99.555 
60119.4 99.471 
 
7.5 
81320.2 98.627 
98.886 
±0.594 
81213.6 98.465 
81935.8 99.565 
 
Inter-day: 
The interday precision for Gabapentin and Amitriptyline Hydrochloride is shown in table (6 & 7). The % RSD for interday 
precision was found to be 1.114 for Gabapentin and 0.926 for Amitriptyline. 
Table 6: Inter-day precision study GABA 
Concentration 
(µg/ml) 
Area 
% 
Recovery 
Avg % 
Recovery ± 
SD 
Mean % 
Recovery ±  
% RSD 
300 
14033.4 99.947 
100.503 ± 
0.604 
99.888 ± 
1.114 
14296.7 101.146 
14136.2 100.415 
600 
35181.4 98.112 
99.410± 
1.133 
35975.6 99.919 
36098.4 100.199 
900 
58943.7 101.467 99.752 ± 
1.538 57510.3 99.292 
                                 
                                        
Table 7: Inter-day precision of AMTR 
Concentration 
(µg/ml) 
Area 
% 
Recovery 
Avg % 
Recovery± 
SD 
Mean%                   
Recovery±              
% RSD 
2.5 
38724.6 101.114  
100.490 ± 
0.582 
100.414 
± 0.926 
38472.6 99.962 
38567.4 100.395 
5 
61054.8 101.609 
100.549 ± 
0.999 
60187.2 99.626 
60530.8 100.411 
7.5 
81467.2 98.851 
100.202± 
1.421 
83325.9 101.684 
82267.4 100.071 
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Accuracy: 
The accuracy of the method was confirmed by recovery 
study from the marketed formulation at three level of 
standard addition. The results are shown in table (8 & 9) 
Table 8: Recovery studies of GABA 
Level 
Conc. (µg/ml) 
Area 
% 
Recovery 
Mean % 
Recovery 
± RSD Sample Std. 
50 % 300 150 
24886.5 99.571 
99.571 ± 
0.633 
25094.1 100.201 
24678.7 98.940 
100 
% 
300 300 
35281.4 98.339 
100.001± 
1.525 
36154.7 100.327 
36154.7 101.337 
150 
% 
300 450 
47486.4 100.532 
100.678 ± 
0.863 
47878.5 101.611 
46934.1 99.891 
                            
Table 9: Recovery studies of AMTR 
Level 
Conc. (µg/ml) 
Area 
% 
Recovery 
Mean % 
Recovery 
± RSD Sample Std. 
50 % 5 2.5 
83467.2 101.899 
101.066 ± 
0.863 
82325.9 100.160 
82967.4 101.138 
100 
% 
5 5 
104260.4 100.194 
100.469 ± 
0.760 
105256.7 101.333 
103987.1 99.881 
150 
% 
5 7.5 
126196.7 100.216 
100.590 ± 
0.816 
127634.5 101.530 
125986.3 100.023 
 
Table 10: System suitability parameters 
Parameters GABA AMTR 
Retention time (min) 1.88 2.38 
Area 32361.3 73401.5 
Plates 475.98 665.02 
Resolution 0.44 1.42 
 
Limit of detection (LOD) and Limit of Quantification 
(LOQ): 
 In the present study, the LOD and LOQ were calculated 
according to the standard deviation of the response and the 
slope of the calibration curve i.e., 3.3σ / S and 10σ / S 
criterions, respectively; where σ is the standard deviation of 
y-intercepts of regression lines and S is the slope of the 
calibration curve. The LOD of GABA and AMTR was found to 
be 121.032ng/band and 0.289/band and LOQ was 
366.765ng/ band and 0.876ng/band for GABA and AMTR, 
respectively.  
Specificity: 
Specificity of the RP-HPLC method was determined by entire 
separation of GABA and AMTR with parameter like retention 
time (tR), resolution (Rs), and tailing factor (T). The peak 
obtained for GABA and AMTR were sharp and have clear 
baseline separation. The results are shown in table (11). 
Table 11: Specificity parameters 
Parameters GABA AMTR 
Tailing factor (T) 0.93 1.74 
Resolution (Rs) 0.44 1.42 
Retention time (tR) 1.88 2.38 
 
Robustness: 
This was done by minute change in the chromatographic 
conditions and found to be unchanged by minute change like 
± 2% change in volume of organic solution of mobile phase.   
4. RESULT AND DISCUSSION 
In this method 1000 ml of mobile phase was prepared by 
mixing 600 ml acetonitrile and 400 ml 0.1 % 
Orthophosphoric acid. The degassed mobile phase was 
filtered through 0.45 μm filters to avoid the column clogging 
due to smaller particles. The flow rate was found to be 
optimum at 1ml/ min resulting in short retention time, good 
baseline stability with low noise level. In the present 
developed RP-HPLC method, the standard and sample 
preparation required less time and no tedious extraction 
was involved. By the use of the proposed method the 
retention time of GABA and AMTR was found to be 1.88 
minutes and 2.38 minutes respectively. The assay of GABA 
and AMTR in bulk drug and in combined tablet dosage form 
was found to be 99.937% and 99.808%. A good linear 
relationship, r 2 =0.995 for GABA and r 2 =0.999 for AMTR 
was observed between the concentration range of 300- 
1500μg/ml and 2.5-12.5μg/ml respectively. The LOD values 
were found to be 121.032μg/ml and 0.289μg/ml and LOQ 
values were found to be 366.765μg/ml 0.876μg/ml for both 
GABA and AMTR respectively. Low values of standard 
deviation of retention time and peak areas indicate high 
precision of the method. From the recovery studies data, it 
was found that the mean % recovery was within the limits, 
indicated high accuracy of the proposed method. There are 
no additional peaks observed in the chromatogram, which 
indicates non-interference of the common excipients used in 
the formulation. No marked changes were observed in % 
assay of the optimized conditions with that of the altered 
conditions in the robustness study indicating that the 
method is robust. 
5. CONCLUSION 
A simple and competent method was developed for the 
simultaneous estimation of Gabapentin and Amitriptyline 
hydrochloride within a short analysis time with no 
interference of the common additives present in the 
pharmaceutical formulation. The proposed method can be 
applied for routine quality control and analysis in bulk and 
in tablet dosage forms. 
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